Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Medical Packaging and Unit Dose Labeling Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325991 - Custom Compounding of Purchased ResinsView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Provide secondary packaging, unit dose blister packing, and labeling compliant with MMS NO. 1 and MIL-STD-129 for military medical logistics tracking.

Similar Contracts

Same NAICS industry code

NAICS: 325991
New
SLED
Holographic Security Feature SupplyThe contract seeks the supply of 5mm-wide holographic security strips designed for integration into thermal ticket rolls to deter counterfeiting, with strict compatibility requirements to align with a PMS281C blue tint. The security strips must be engineered to maintain visual and functional integrity under the specific thermal printing conditions used in ticket production, ensuring consistent performance and readability across large-volume deployments. The work is classified as a subcontract under NAICS code 325991, indicating it falls within the broader category of other chemical product and preparation manufacturing, and the performance location is tied to the operations of Dallas Area Rapid Transit in Texas. The opportunity was posted on July 20, 2026, with a tight response deadline of July 24, 2026, indicating a rapid procurement cycle. Interested suppliers must deliver proposals within this four-day window to be considered, and the contract will be awarded to a qualified vendor capable of meeting the technical specifications for holographic security features. While no set-aside designation or point of contact is provided, the sourcing authority is clearly identified as Dallas Area Rapid Transit, and all submissions must be made through the designated platform linked in the contract data. Successful bidders will be expected to ensure full compliance with material specifications and supply chain reliability to support ongoing transit ticketing operations.
Dallas Area Rapid Transit

POSTED

3 days ago

DEADLINE

in 1 day
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, is provided in collapsible tubes of 28.35 grams, with the unit of issue designated as a tube (TU). The product is regulated by the FDA and must comply with strict technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including packaging standards under MIL-STD-129 and commercial packaging per ASTM D3951 when non-hazardous, with DLA requirements superseding all other standards. Labeling must adhere to the latest Medical Marking Standard No. 1, and shelf life is fixed at 36 months without extension. Storage requires controlled room temperature not exceeding 30°C (86°F). The ointment is supplied by DYNAREX CORP under NDC 67777-0223-11 and part number 1190, with traceable shipping mandated and parcel post prohibited. Two delivery lines are specified: three tubes to Morrisville, NC with a July 24, 2026 delivery deadline and six tubes to Fort Bragg, NC with a July 27, 2026 deadline, both delivered FOB destination with zero quantity variance permitted. Inspection and acceptance occur at the delivery point, and packaging must meet DLA's RP001 packaging and palletization requirements. All shipments must include government-identifying information per contract specifications and be tracked through authenticated logistics channels.
Pharmaceutical Preparation Manufacturing

POSTED

about 19 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.
Pharmaceutical Preparation Manufacturing

POSTED

about 19 hours ago

DEADLINE

in 5 days
View Details